Search research articles
Contact Us
Filters
Showing results (1-10 of 11) with videos related to
Page
of 2
Sort By:
Cellular and Molecular Life Sciences : CMLS
|
January 5, 2002
Inner nuclear membrane proteins: functions and targeting
L Holmer, H J Worman
Genomics
|
January 8, 1999
The human lamin B receptor/sterol reductase multigene family
L Holmer, A Pezhman, H J Worman
Somatic Cell and Molecular Genetics
|
April 14, 2000
A human HP1 pseudogene maps to chromosome 11p14
A Park, L Holmer, H J Worman
Annals of the New York Academy of Sciences
|
July 20, 2001
Convective heat transfer on an inlet guide vane
M L Holmer, L E Eriksson, B Sunden
Reproductive Toxicology (Elmsford, N.Y.)
|
July 10, 2024
Methodology for developing data-rich Key Event Relationships for Adverse Outcome Pathways exemplified by linking decreased androgen receptor activity with decreased anogenital distance
Marie L Holmer, Johanna Zilliacus, Monica K Draskau, et al.
Environmental Toxicology and Chemistry
|
September 1, 2025
AOP report: Adverse Outcome Pathway Network for Developmental Androgen Signalling-Inhibition Leading to Short Anogenital Distance in Male Offspring
Terje Svingen, Emilie Elmelund, Marie L Holmer, et al.
The Journal of Biological Chemistry
|
February 15, 2000
MAN1, an inner nuclear membrane protein that shares the LEM domain with lamina-associated polypeptide 2 and emerin
F Lin, D L Blake, I Callebaut, et al.
Regulatory Toxicology and Pharmacology : RTP
|
December 6, 2012
Meeting report: international workshop on endocrine disruptors: exposure and potential impact on consumers health
C Rousselle, J N Ormsby, B Schaefer, et al.
Environmental Toxicology and Chemistry
|
August 29, 2024
AOP Report: An Upstream Network for Reduced Androgen Signaling Leading to Altered Gene Expression of Androgen Receptor-Responsive Genes in Target Tissues
Monica K Draskau, Anna K Rosenmai, Nora Bouftas, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 2, 1999
BEACOPP: a new regimen for advanced Hodgkin's disease. German Hodgkin's Lymphoma Study Group
V Diehl, J Franklin, D Hasenclever, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 11) with videos related to
Sort By:
Page
of 2
Cellular and Molecular Life Sciences : CMLS
|
January 5, 2002
Inner nuclear membrane proteins: functions and targeting
L Holmer, H J Worman
Genomics
|
January 8, 1999
The human lamin B receptor/sterol reductase multigene family
L Holmer, A Pezhman, H J Worman
Somatic Cell and Molecular Genetics
|
April 14, 2000
A human HP1 pseudogene maps to chromosome 11p14
A Park, L Holmer, H J Worman
Annals of the New York Academy of Sciences
|
July 20, 2001
Convective heat transfer on an inlet guide vane
M L Holmer, L E Eriksson, B Sunden
Reproductive Toxicology (Elmsford, N.Y.)
|
July 10, 2024
Methodology for developing data-rich Key Event Relationships for Adverse Outcome Pathways exemplified by linking decreased androgen receptor activity with decreased anogenital distance
Marie L Holmer, Johanna Zilliacus, Monica K Draskau, et al.
Environmental Toxicology and Chemistry
|
September 1, 2025
AOP report: Adverse Outcome Pathway Network for Developmental Androgen Signalling-Inhibition Leading to Short Anogenital Distance in Male Offspring
Terje Svingen, Emilie Elmelund, Marie L Holmer, et al.
The Journal of Biological Chemistry
|
February 15, 2000
MAN1, an inner nuclear membrane protein that shares the LEM domain with lamina-associated polypeptide 2 and emerin
F Lin, D L Blake, I Callebaut, et al.
Regulatory Toxicology and Pharmacology : RTP
|
December 6, 2012
Meeting report: international workshop on endocrine disruptors: exposure and potential impact on consumers health
C Rousselle, J N Ormsby, B Schaefer, et al.
Environmental Toxicology and Chemistry
|
August 29, 2024
AOP Report: An Upstream Network for Reduced Androgen Signaling Leading to Altered Gene Expression of Androgen Receptor-Responsive Genes in Target Tissues
Monica K Draskau, Anna K Rosenmai, Nora Bouftas, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 2, 1999
BEACOPP: a new regimen for advanced Hodgkin's disease. German Hodgkin's Lymphoma Study Group
V Diehl, J Franklin, D Hasenclever, et al.
Page
of 2